TEVA
Teva Pharma Industries Ltd ADR
NYSE: TEVA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.07
-0.88% today
Updated 2026-04-30
Market cap
$41.20B
P/E ratio
26.40
P/S ratio
2.39x
EPS (TTM)
$1.34
Dividend yield
—
52W range
$15 – $37
Volume
6.8M
Teva Pharma Industries Ltd ADR (TEVA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $20.47B | $23.41B | $32.90B | $33.81B | $39.05B | $50.14B | $50.61B | $47.51B | $46.42B | $54.26B | $92.89B | $70.61B | $60.68B | $57.47B | $50.64B | $47.67B | $44.01B | $43.48B | $39.33B | $40.75B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $7.64B | $9.86B | $11.43B | $12.14B | $12.24B | $14.45B | $16.36B | $13.72B | $14.40B | $18.40B | $16.96B | $15.38B | $13.79B | $13.46B | $13.01B | $12.57B | $12.05B | $12.48B | $12.55B | $13.95B |
| Total liabilities | $9.29B | $9.65B | $16.54B | $14.55B | $17.05B | $27.80B | $27.74B | $24.87B | $23.07B | $24.33B | $57.90B | $51.87B | $44.89B | $42.41B | $39.58B | $36.42B | $35.41B | $35.35B | $33.61B | $32.83B |
| Current liabilities | $4.07B | $5.37B | $8.48B | $7.60B | $9.89B | $13.85B | $12.89B | $11.96B | $12.29B | $13.01B | $18.52B | $17.92B | $14.32B | $13.67B | $13.16B | $11.03B | $11.47B | $12.25B | $12.80B | $13.46B |
| Long-term debt | $4.58B | $3.35B | $5.54B | $4.31B | $4.11B | $10.24B | $11.71B | $10.39B | $8.57B | $8.35B | $32.52B | $28.83B | $26.70B | $24.56B | $22.73B | $21.62B | $19.10B | $18.16B | $16.00B | $14.99B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $3.40B | $5.04B | $5.29B | $6.66B | $9.32B | $11.28B | $12.35B | $12.54B | $14.44B | $14.85B | $13.61B | $-3.80B | $-5.96B | $-6.96B | $-10.95B | $-10.53B | $-12.97B | $-13.53B | $-15.17B | $-13.76B |
| Accounts receivable | $2.92B | $3.55B | $4.65B | $5.02B | $5.48B | $6.21B | $5.57B | $5.34B | $5.41B | $5.35B | $7.52B | $7.13B | $5.82B | $5.68B | $4.58B | $4.53B | $3.70B | $3.41B | $3.06B | $3.71B |
| Inventory | $1.88B | $2.44B | $3.40B | $3.33B | $3.87B | $5.01B | $5.50B | $5.05B | $4.37B | $3.97B | $4.95B | $4.92B | $4.73B | $4.42B | $4.40B | $3.82B | $3.83B | $4.02B | $3.01B | $3.18B |
| Goodwill | $8.04B | $8.41B | $12.30B | $12.67B | $15.23B | $18.29B | $18.86B | $18.98B | $18.41B | $19.02B | $44.41B | $28.41B | $24.92B | $24.85B | $20.62B | $20.04B | $17.63B | $17.18B | $15.15B | $16.00B |